3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
141
Active not recruiting
58
Completed
34
Not yet recruiting
26
Terminated
12
Enrolling by invitation
4
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
10
Breast Neoplasms
9
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
7
Lung Neoplasms
6
Glioblastoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Hematologic Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Multiple Myeloma
4
Carcinoma, Renal Cell
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Melanoma
3
Head and Neck Neoplasms
3
Urinary Bladder Neoplasms
2
Solid Tumor
2
Recurrence
2
Rectal Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Osteosarcoma
2
Neoplasm, Residual
2
NSCLC
2
Interventions
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Squamous Cell Carcinoma of Head and Neck
×
90 days
×
Clear all
NCT04266730
2026-04-23
PANDA-VAC
UNC Lineberger Comprehensive Cancer Center
Phase 1
Suspended
6 enrolled